Patient Guide: A Study to Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Treat Participants With Moderate Plaque Psoriasis and Who Need to Try Systemic Treatment (Works Throughout the Whole Body)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 88 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06333860
Status: ACTIVE_NOT_RECRUITING
Condition: Moderate Plaque Psoriasis
Phase: PHASE4

Where You Can Participate

This study is available at 88 locations across the country.

Top locations include:
  • • Birmingham, Alabama
  • • Glendale, Arizona
  • • Scottsdale, Arizona
  • • And 85 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Treat Participants With Moderate Plaque Psoriasis and Who Need to Try Systemic Treatment (Works Throughout the Whole Body) - Join Clinical Trial NCTNCT06333860

How to Join This Clinical Trial - NCTNCT06333860

Learn how to participate in this PHASE4 trial studying an investigational therapy for Moderate Plaque Psoriasis. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Moderate Plaque Psoriasis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Moderate Plaque Psoriasis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE4 - Research study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT06333860 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 88 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35205 - United States

Status: Contact for availability

Clinical Research Site

Glendale, Arizona 85308 - United States

Status: Contact for availability

Clinical Research Site

Scottsdale, Arizona 85260 - United States

Status: Contact for availability

Clinical Research Site

Bryant, Arkansas 72022 - United States

Status: Contact for availability

Clinical Research Site

Fountain Valley, California 92708 - United States

Status: Contact for availability

Clinical Research Site

Sacramento, California 95815 - United States

Status: Contact for availability

Clinical Research Site

Sacramento, California 95825 - United States

Status: Contact for availability

Clinical Research Site

San Diego, California 92103 - United States

Status: Contact for availability

Clinical Research Site

Santa Ana, California 92701 - United States

Status: Contact for availability

Clinical Research Site

Boca Raton, Florida 33428 - United States

Status: Contact for availability

And 78 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE4 clinical trial for Moderate Plaque Psoriasis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships